214 related articles for article (PubMed ID: 36693016)
1. Role of Human Aldo-Keto Reductases and Nuclear Factor Erythroid 2-Related Factor 2 in the Metabolic Activation of 1-Nitropyrene via Nitroreduction in Human Lung Cells.
Su AL; Penning TM
Chem Res Toxicol; 2023 Feb; 36(2):270-280. PubMed ID: 36693016
[TBL] [Abstract][Full Text] [Related]
2. Induction of the Antioxidant Response by the Transcription Factor NRF2 Increases Bioactivation of the Mutagenic Air Pollutant 3-Nitrobenzanthrone in Human Lung Cells.
Murray JR; de la Vega L; Hayes JD; Duan L; Penning TM
Chem Res Toxicol; 2019 Dec; 32(12):2538-2551. PubMed ID: 31746589
[TBL] [Abstract][Full Text] [Related]
3. Role of Human Aldo-Keto Reductases in the Nitroreduction of 1-Nitropyrene and 1,8-Dinitropyrene.
Su AL; Mesaros CA; Krzeminski J; El-Bayoumy K; Penning TM
Chem Res Toxicol; 2022 Dec; 35(12):2296-2309. PubMed ID: 36399404
[TBL] [Abstract][Full Text] [Related]
4. Role of Human Aldo-Keto Reductases in the Metabolic Activation of the Carcinogenic Air Pollutant 3-Nitrobenzanthrone.
Murray JR; Mesaros CA; Arlt VM; Seidel A; Blair IA; Penning TM
Chem Res Toxicol; 2018 Nov; 31(11):1277-1288. PubMed ID: 30406992
[TBL] [Abstract][Full Text] [Related]
5. Identification of aldo-keto reductases as NRF2-target marker genes in human cells.
Jung KA; Choi BH; Nam CW; Song M; Kim ST; Lee JY; Kwak MK
Toxicol Lett; 2013 Mar; 218(1):39-49. PubMed ID: 23305850
[TBL] [Abstract][Full Text] [Related]
6. Human exposure to diesel exhaust induces CYP1A1 expression and AhR activation without a coordinated antioxidant response.
Friberg M; Behndig AF; Bosson JA; Muala A; Barath S; Dove R; Glencross D; Kelly FJ; Blomberg A; Mudway IS; Sandström T; Pourazar J
Part Fibre Toxicol; 2023 Dec; 20(1):47. PubMed ID: 38062420
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
[TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29.
Ebert B; Kisiela M; Wsól V; Maser E
Chem Biol Interact; 2011 May; 191(1-3):239-49. PubMed ID: 21215737
[TBL] [Abstract][Full Text] [Related]
9. Specificity of human aldo-keto reductases, NAD(P)H:quinone oxidoreductase, and carbonyl reductases to redox-cycle polycyclic aromatic hydrocarbon diones and 4-hydroxyequilenin-o-quinone.
Shultz CA; Quinn AM; Park JH; Harvey RG; Bolton JL; Maser E; Penning TM
Chem Res Toxicol; 2011 Dec; 24(12):2153-66. PubMed ID: 21910479
[TBL] [Abstract][Full Text] [Related]
10. Human aldo-keto reductases and the metabolic activation of polycyclic aromatic hydrocarbons.
Penning TM
Chem Res Toxicol; 2014 Nov; 27(11):1901-17. PubMed ID: 25279998
[TBL] [Abstract][Full Text] [Related]
11. Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer.
MacLeod AK; Acosta-Jimenez L; Coates PJ; McMahon M; Carey FA; Honda T; Henderson CJ; Wolf CR
Br J Cancer; 2016 Dec; 115(12):1530-1539. PubMed ID: 27824809
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole induces NAD(P)H quinone oxidoreductase 1 via aryl hydrocarbon receptor-independent mechanisms: Role of the transcription factor nuclear factor erythroid 2-related factor 2.
Zhang S; Patel A; Moorthy B; Shivanna B
Biochem Biophys Res Commun; 2015 Nov; 467(2):282-7. PubMed ID: 26441083
[TBL] [Abstract][Full Text] [Related]
13. Tissue distribution, ontogeny, and chemical induction of aldo-keto reductases in mice.
Pratt-Hyatt M; Lickteig AJ; Klaassen CD
Drug Metab Dispos; 2013 Aug; 41(8):1480-7. PubMed ID: 23660342
[TBL] [Abstract][Full Text] [Related]
14. Aldo-keto reductase 1C2 is essential for 1-nitropyrene's but not for benzo[a]pyrene's induction of p53 phosphorylation and apoptosis.
Su JG; Liao PJ; Huang MC; Chu WC; Lin SC; Chang YJ
Toxicology; 2008 Feb; 244(2-3):257-70. PubMed ID: 18207300
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of (+/-)-benzo[a]pyrene-trans-7,8-dihydrodiol activation by human cytochrome P450 and aldo-keto reductase enzymes: effect of redox state and expression levels.
Quinn AM; Penning TM
Chem Res Toxicol; 2008 May; 21(5):1086-94. PubMed ID: 18402469
[TBL] [Abstract][Full Text] [Related]
16. Enhanced 4-hydroxynonenal resistance in KEAP1 silenced human colon cancer cells.
Jung KA; Kwak MK
Oxid Med Cell Longev; 2013; 2013():423965. PubMed ID: 23766854
[TBL] [Abstract][Full Text] [Related]
17. Nitroreduction: A Critical Metabolic Pathway for Drugs, Environmental Pollutants, and Explosives.
Penning TM; Su AL; El-Bayoumy K
Chem Res Toxicol; 2022 Oct; 35(10):1747-1765. PubMed ID: 36044734
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of inducible aldo-keto reductases on 4-hydroxynonenal- induced hepatotoxicity.
Li D; Gu Z; Zhang J; Ma S
Chem Biol Interact; 2019 May; 304():124-130. PubMed ID: 30849339
[TBL] [Abstract][Full Text] [Related]
19. Luteolin modulates expression of drug-metabolizing enzymes through the AhR and Nrf2 pathways in hepatic cells.
Zhang T; Kimura Y; Jiang S; Harada K; Yamashita Y; Ashida H
Arch Biochem Biophys; 2014 Sep; 557():36-46. PubMed ID: 24914470
[TBL] [Abstract][Full Text] [Related]
20. Identification of the major metabolites and DNA adducts formed from 2-nitropyrene in vitro.
Roy AK; Upadhyaya P; Fu PP; el-Bayoumy K
Carcinogenesis; 1991 Mar; 12(3):475-9. PubMed ID: 2009592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
